GVIRF 2021: Keynote by Anthony Fauci, NIAID
GVIRF 2021: Epidemic and Pandemic Preparedness and Response
GVIRF 2021: Emerging Platforms
GVIRF 2021: Innovations in Vaccine Manufacturing
GVIRF 2021: Innovation in Vaccination
GVIRF 2021: Fenton Hall Introduction
GVIRF 2021 Day 2
GVIRF 2021: Keynotes by Bill Gates, Bill & Melinda Gates Foundation, and Anuradha Gupta, Gavi, the Vaccine Alliance
GVIRF 2021: HIV, TB & Malaria Vaccine R&D Update
GVIRF 2021: New and Improved Vaccines on the Horizon
GVIRF 2021: Controlled Human Infection Models for Vaccine R&D
GVIRF 2021: Vaccine development to access: is there a role for early policy consideration?
GVIRF 2021 Day 3
GVIRF 2021: Keynote by Soumya Swaminathan, WHO
GVIRF 2021: Shaping the Future: Equitable Access for All
GVIRF 2021: Prioritization for Vaccine R&D
GVIRF 2021: Immune Responses over the Life Course
GVIRF 2021: Building and Sustaining Uptake